Abstract
Considerable developments in nuclear medicine imaging technology have occurred in the past decade, with SPECT/CT obtained on hybrid gamma cameras with in-line CT proving to be a powerful diagnostic tool that allows for accurate anatomic localization and characterization of radioactivity distributions. SPECT/CT has substantially improved the interpretation of radioiodine scintigraphy for evaluation of well-differentiated thyroid cancer, using both post-therapeutic and diagnostic 131-I administered activities. SPECT/CT contributes to risk stratification and completion of staging by improved characterization of N and M scores. The information obtained from SPECT/CT impacts patient management and contributes important prognostic information. The new technology of SPECT/CT has significant potential to change the current management protocols and guidelines in thyroid cancer.
| Original language | English (US) |
|---|---|
| Title of host publication | Clinical Applications of SPECT-CT, Second Edition |
| Publisher | Springer International Publishing |
| Pages | 72-93 |
| Number of pages | 22 |
| ISBN (Electronic) | 9783030658502 |
| ISBN (Print) | 9783030658496 |
| DOIs | |
| State | Published - Jan 1 2021 |
Keywords
- 131-I SPECT/CT
- Diagnostic radioiodine scan
- Post-therapy scan
- Pre-ablation scan
- Radioiodine scan
- Radioiodine SPECT/CT
- SPECT/CT
- Thyroid cancer
ASJC Scopus subject areas
- General Medicine
